Cardiovascular mortality in chronic kidney disease patients undergoing percutaneous coronary intervention is mainly related to impaired P2Y12 inhibition by clopidogrel - Morel, O; El Ghannudi, S; Jesel, L (J Am Coll Cardiol, 2011)